Moreover, the World Health Organization (WHO) recommends the tuberculosis lipoarabinomannan antigen, shown to increase diagnoses and reduce mortality rates in PLHIV with CD4 cell counts <100/μL [27]. This evidence concerns the gene CD4 and tuberculosis.